These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 22106645)

  • 1. Content audit of drug advertisements in Pakistan.
    Vakani F; Naqv K; Amin A
    Indian J Med Ethics; 2011; 8(3):167-9. PubMed ID: 22106645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A study of promotional advertisements of drugs in a medical journal: an ethics perspective.
    Nath S; Bhowmick S; Dutta T; Chowrasia VR; Bhattacharya S; Chatterjee RN; Sarkar M; Ram AK; Mukherjee PK
    Indian J Med Ethics; 2014; 11(4):237-41. PubMed ID: 25377037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Supported and unsupported claims in medicinal drug advertisements in Indian medical journals.
    Dhanaraj E; Nigam A; Bagani S; Singh H; Tiwari P
    Indian J Med Ethics; 2011; 8(3):170-4. PubMed ID: 22106646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Critical evaluation of the claims made by pharmaceutical companies in drug promotional material in Pakistan.
    Rohra DK; Gilani AH; Memon IK; Perven G; Khan MT; Zafar H; Kumar R
    J Pharm Pharm Sci; 2006; 9(1):50-9. PubMed ID: 16849008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug advertisements in two dermatology journals: a critical comparison of IJDVL and JAAD.
    Gahalaut P; Chauhan S; Mishra N; Rastogi M; Thakur R
    Indian J Dermatol Venereol Leprol; 2014; 80(2):115-21. PubMed ID: 24685846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. College activities and the ethics of advertising.
    Ryan C; Walter G; Robertson M
    Australas Psychiatry; 2010 Apr; 18(2):101-5. PubMed ID: 20307152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The accuracy of psychiatric medication advertisements in medical journals.
    Spielmans GI; Thielges SA; Dent AL; Greenberg RP
    J Nerv Ment Dis; 2008 Apr; 196(4):267-73. PubMed ID: 18414120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ensuring ethical drug promotion--whose responsibility?
    Quick JD; Hogerzeil HV; Rägo L; Reggi V; de Joncheere K
    Lancet; 2003 Aug; 362(9385):747. PubMed ID: 12957107
    [No Abstract]   [Full Text] [Related]  

  • 9. Adherence of pharmaceutical advertisements in medical journals to FDA guidelines and content for safe prescribing.
    Korenstein D; Keyhani S; Mendelson A; Ross JS
    PLoS One; 2011; 6(8):e23336. PubMed ID: 21858076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonpropositional content in direct-to-consumer genetic testing advertisements.
    Borry P; Shabani M; Howard HC
    Am J Bioeth; 2013; 13(5):14-6. PubMed ID: 23557036
    [No Abstract]   [Full Text] [Related]  

  • 11. Drug firms vow to tone down consumer advertisements.
    Wadman M
    Nat Med; 2005 Sep; 11(9):910. PubMed ID: 16145559
    [No Abstract]   [Full Text] [Related]  

  • 12. Monitoring misuse of the WHO name and emblem in medicine promotion in India.
    Thawani V; Gharpure K
    Indian J Med Ethics; 2009; 6(1):10-4. PubMed ID: 19241948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Claims in advertisements for antihypertensive drugs in a Dutch medical journal.
    Greving JP; Denig P; de Zeeuw D; Haaijer-Ruskamp FM
    J Hypertens; 2007 Mar; 25(3):713-22. PubMed ID: 17278989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The politics and strategy of industry self-regulation: the pharmaceutical industry's principles for ethical direct-to-consumer advertising as a deceptive blocking strategy.
    Arnold DG; Oakley JL
    J Health Polit Policy Law; 2013 Jun; 38(3):505-44. PubMed ID: 23418365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Food and Drug Administration surveillance of dermatology-related and nondermatology-related prescription drug advertising in the USA, 2000-2003.
    Cowden AL; Katz KA
    Br J Dermatol; 2006 May; 154(5):950-8. PubMed ID: 16634900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Misleading promotion of drugs in Bangladesh: evidence from drug promotional brochures distributed to general practitioners by the pharmaceutical companies.
    Islam MS; Farah SS
    J Public Health (Oxf); 2007 Jun; 29(2):212-3. PubMed ID: 17513315
    [No Abstract]   [Full Text] [Related]  

  • 17. [Drug advertising as communication between the pharmaceutical industry and the physician: advertisements for psychotropic drugs in the Dutch medical journal, Nederlands Tijdschrift voor Geneeskunde, 1900-1940].
    van der Hoogte AR; Pieters T
    Studium (Rotterdam); 2010; 3(4):139-54. PubMed ID: 22586821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ban drug advertisements.
    Lexchin J
    CJEM; 2011 Sep; 13(5):297. PubMed ID: 21955408
    [No Abstract]   [Full Text] [Related]  

  • 19. Are claims of advertisements in medical journals supported by RCTs?
    Heimans L; van Hylckama Vlieg A; Dekker FW
    Neth J Med; 2010 Jan; 68(1):46-9. PubMed ID: 20103825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Bioethical analysis of drugs advertisement and publicity].
    Fagundes MJ; Soares MG; Diniz NM; Pires JR; Garrafa V
    Cien Saude Colet; 2007; 12(1):221-9. PubMed ID: 17680073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.